BOSTON LIFE SCIENCES Aktie

0,08 EUR 0,0000%

Zu Ihrem Onlinebroker

kaufen verkaufen

BOSTON LIFE SCIENCES Aktienkurs : 15:34 ( 15 Min. verzögert)
0,0750 € Letzter Kurs	0,00% Veränderung	0,0750 € Vortag	0,0750 € Eröffnungskurs

Realtime:

0,08

0,00%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,0750 - 0,0750 Tag	0,237 - 0,0010 52 Wochen	0 Tag	474 Ø 52 Wochen	0,0520 66.400 Stücke	0,132 26.200 Stücke

BOSTON LIFE SCIENCES Aktienku…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

21.05.

Report: Foreign countries want to lure US biotechs

The Boston life sciences cluster has long been regarded as among the top biotech clusters in the nation, along with the San Francisco Bay...
14.05.

XENETIC BIOSCIENCES PLC : - Appointment of VP for Drug Development

... the global Bio International Convention being held in Boston when the Governor of Massachusetts will be announcing Xenetic's introduction to the Boston Life Sciences hub. The Company is currently in ...

11.05.

BioMed Realty Trust Signs Aveo Pharmaceuticals to 126 KSF Office Lease

By Barbra Murray, Contributing Editor Signs of life are crystal clear in the Cambridge market of metropolitan Boston's life-sciences sector, as evidenced by a sizeable new lease secured by BioMed…
11.05.

Boston Life Sciences News From Vertex, Eleven, RXi, & More

News of financings, clinical developments, hires, and IPO moves came out of New England life sciences companies this week. —RXi Pharmaceuticals, a Worcester, MA-based biotech working in the area of R…
10.05.

BioSurplus Appoints Michelle Crandall to Lead Boston Expansion

Many greater Boston life sciences companies already rely on BioSurplus' online services to maximize the value of their scientific instrument. The planned BioSurplus Boston showroom...